Skip to main content

.

Search

Dr. Deepak Bhatt and Dr. C. Michael Gibson discuss: TRANQUILITY: Efficacy of monthly and quarterly dosing of pacibekitug (IL-6 ligand mAb) targeting inflammation in CKD with high cardiovascular risk